BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 231068)

  • 21. [Clinico-pathological studies on herpes zoster; [I]. Changes in antibody titers on herpes zoster].
    Muraki R
    Nihon Hifuka Gakkai Zasshi; 1986 Jan; 96(1):1-7. PubMed ID: 3009931
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1971 Jul; 15(4):293-300. PubMed ID: 4398080
    [No Abstract]   [Full Text] [Related]  

  • 23. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.
    Gershon AA; Steinberg SP; Borkowsky W; Lennette D; Lennette E
    Pediatr Infect Dis; 1982; 1(3):164-7. PubMed ID: 6292875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
    Wolff MH; Marklein G; Schneweis KE; Stifter G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
    [No Abstract]   [Full Text] [Related]  

  • 25. Indirect hemagglutination test for varicella-zoster infection.
    Furukawa T; Plotkin SA
    Infect Immun; 1972 Jun; 5(6):835-9. PubMed ID: 4344091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes zoster during varicella.
    Lau BH; Lin MI; Lin HC
    Pediatr Infect Dis J; 2001 Sep; 20(9):915-6. PubMed ID: 11734778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.
    Wong CL; Castriciano S; Chernesky MA; Rawls WE
    J Clin Microbiol; 1978 Jan; 7(1):6-11. PubMed ID: 203604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
    Gallo D; Schmidt NJ
    J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 33. [Does vaccination for chickenpox prevent herpes zoster? (interview by Waldtraut Paukstadt)].
    Doerr HW
    MMW Fortschr Med; 2002 Dec; 144(50):12. PubMed ID: 14610859
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: Varicella-zoster infections: zoster immune globulin.
    Hussey HH
    JAMA; 1974 May; 228(7):876. PubMed ID: 4362716
    [No Abstract]   [Full Text] [Related]  

  • 35. [Varicella-zoster virus infection and the serologic determination of first-infection immunity].
    Schneweis KE; Krentler C; Wolff MH
    Dtsch Med Wochenschr; 1985 Mar; 110(12):453-7. PubMed ID: 2983965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
    J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.
    Schaap GJ; Huisman J
    Arch Gesamte Virusforsch; 1968; 25(1):52-7. PubMed ID: 4306835
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation of concentrated intracellular precipitating antigens of varicella-zoster and herpes simplex viruses and results obtained with them in the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1970 Jan; 14(1):25-34. PubMed ID: 4392074
    [No Abstract]   [Full Text] [Related]  

  • 40. The development and evaluation of a solid-phase radioimmunoassay (RIA) procedure for the determination of susceptibility to varicella.
    Campbell-Benzie A; Kangro HO; Heath RB
    J Virol Methods; 1981 Feb; 2(3):149-58. PubMed ID: 6268649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.